BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5919308)

  • 1. [Interactions between adrenergics, adrenolytics and monoamine oxidase inhibitors].
    Marmo E; Sarluca F
    Clin Ter; 1966 Apr; 37(1):3-24. PubMed ID: 5919308
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of desipramine, cocaine and xylocholine on 5-hydroxytryptamine, adrenaline and vagus stimulation induced tonus decrease of smooth frog lung musculature].
    Schnizer W
    Arzneimittelforschung; 1969 Apr; 19(4):663-5. PubMed ID: 5819171
    [No Abstract]   [Full Text] [Related]  

  • 3. Meta- and para-hydroxy-1-cyanophenethylamines.
    Pinder RM; Burger A; Ariëns EJ
    Arzneimittelforschung; 1970 Feb; 20(2):245-6. PubMed ID: 4392556
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the pharmacodynamic effect of antidepressive agents in an animal experiment].
    Blum JE
    Wien Klin Wochenschr; 1968 Nov; 80(47):881-7. PubMed ID: 5717658
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of radioprotective sympathomimetics and their combinations with adrenolytics on the concentration of thiols in the spleen].
    Kulinskiĭ VI; Zolochevskaia LI
    Radiobiologiia; 1973; 13(1):46-9. PubMed ID: 4719887
    [No Abstract]   [Full Text] [Related]  

  • 6. Sympathomimetic action of an adrenergic beta receptor blocking agent, 4-(2-isopropylamino-1-hydroxyethyl) methanesulphonanilid hydrochloride (MJ1999).
    Agarwal SL; Bose D; Natu MV; Gandhi IS
    Indian J Med Res; 1968 Feb; 56(2):227-33. PubMed ID: 5657521
    [No Abstract]   [Full Text] [Related]  

  • 7. [Histochemical research on the behavior of certain lysosome hydrolases (AcPase, NA-beta-Gase) of magnocellular hypothalamic nuclei in normal rats and in rats treated with adrenomimetic, adrenolytic and cholinolytic drugs. 1].
    Pasqualino A; Tessitore V
    Biol Lat; 1968; 21(1):1-17. PubMed ID: 5735719
    [No Abstract]   [Full Text] [Related]  

  • 8. [Letter: Monoamine oxidase inhibitors].
    Bolwig TG
    Ugeskr Laeger; 1974 Jul; 136(28):1591. PubMed ID: 4407583
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions of monoamine oxidase inhibition and sympathomimetic amines on the human iris.
    Bevan-Jones B; Lind NA
    Br J Pharmacol; 1971 Feb; 41(2):428P-429P. PubMed ID: 5572317
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of the adrenergic innervation of the oviduct in the regulation of mammalian ovum transport.
    Paton DM; Widdicombe JH; Rheaume DE; Johns A
    Pharmacol Rev; 1977 Jun; 29(2):67-102. PubMed ID: 353829
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction between phenylpropanolamine and monoamine oxidase inhibitors.
    D'Mello A
    J Pharm Pharmacol; 1969 Sep; 21(9):577-80. PubMed ID: 4390334
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of amine oxidase inhibitors, vasodilator and tranquilizing agents on experimental isoproterenol-induced myocardial necrosis].
    ZBINDEN G
    Arzneimittelforschung; 1962 Jun; 12():635-8. PubMed ID: 14009960
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of monoamine oxidase inhibitors on the vasopressor actions of several sympathomimetic agents.
    KONO C; KANDA Z; SEKIYA A; SAJI E
    Nagoya J Med Sci; 1962 Jan; 24():159-70. PubMed ID: 14458230
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neuroleptics, monoamine oxidase inhibitors and dopamine beta hydroxylase inhibitors: their actions and interactions].
    Vetulani J
    Postepy Hig Med Dosw; 1973; 27(6):725-80. PubMed ID: 4589208
    [No Abstract]   [Full Text] [Related]  

  • 15. [Action of a monoamine oxidase inhibitor (Niamid) on various experimental vascular lesions in the rabbit (allergic arteritis, myocardial necrosis caused by isoproterenol, aortic medionecrosis, venous and arterial thrombosis)].
    FABRE J; RUDHARDT M; MICHEL B; LACOURT G; JEANDET J
    Chemotherapia (Basel); 1962; 4():237-47. PubMed ID: 13891221
    [No Abstract]   [Full Text] [Related]  

  • 16. Interactions at adrenergic nerve endings.
    Salerni OL
    J Indiana State Med Assoc; 1972 Jun; 65(6):498-9. PubMed ID: 4643468
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-pharmacological model of paroxysmal arterial hypertension].
    Sicuteri F; Del Bene E; Tarquini B; Fanciullacci M
    Rass Neurol Veg; 1968; 22(1):63-82. PubMed ID: 5718883
    [No Abstract]   [Full Text] [Related]  

  • 18. [Monoamine oxidase inhibitors and cardiac action of G-strophanthin].
    Loubatières A; Bouyard P; Klein M
    C R Seances Soc Biol Fil; 1966; 160(8):1638-42. PubMed ID: 4227883
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological approach to the mechanism of potentiation of hypnotics by various monoamine oxidase inhibitors].
    Simon P; Tillement JP; Lwoff JM; Boissier JR
    Therapie; 1968; 23(4):849-61. PubMed ID: 5744593
    [No Abstract]   [Full Text] [Related]  

  • 20. [Structure-action relations of monoamine oxidase inhibitors].
    Matthies H; Fähse C; Lietz W; Jassmann E
    Acta Biol Med Ger; 1967; 19(3):447-61. PubMed ID: 5591162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.